"Receptors, Leukotriene" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell-surface receptors that bind LEUKOTRIENES with high affinity and trigger intracellular changes influencing the behavior of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes LTB4; LTC4; LTD4; and LTE4.
| Descriptor ID |
D018077
|
| MeSH Number(s) |
D12.776.543.750.695.200.450
|
| Concept/Terms |
Receptors, Leukotriene- Receptors, Leukotriene
- Leukotriene Receptors
- Leukotriene Receptor
- Receptor, Leukotriene
- Receptors, Leukotrienes
- Leukotrienes Receptors
SRS-A Receptors- SRS-A Receptors
- SRS A Receptors
- Slow Reaction Substance of Anaphylaxis Receptors
- Slow Reacting Substance of Anaphylaxis Receptors
- SRS-A Receptor
- Receptor, SRS-A
- SRS A Receptor
- Receptors, SRS-A
- Receptors, SRS A
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Leukotriene".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Leukotriene".
This graph shows the total number of publications written about "Receptors, Leukotriene" by people in this website by year, and whether "Receptors, Leukotriene" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Leukotriene" by people in Profiles.
-
Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19. Pharmacology. 2021; 106(9-10):469-476.
-
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity. Eur J Pharmacol. 2021 Aug 05; 904:174196.
-
As a potential treatment of COVID-19: Montelukast. Med Hypotheses. 2020 Sep; 142:109828.
-
Current state and future prospect of the therapeutic strategy targeting cysteinyl leukotriene metabolism in asthma. Respir Investig. 2019 Nov; 57(6):534-543.
-
Variants in the CYSLTR2 are associated with asthma, atopy markers and helminths infections in the Brazilian population. Prostaglandins Leukot Essent Fatty Acids. 2019 06; 145:15-22.
-
Establishment of a CRISPR/Cas9-Mediated Cysltr1 Knockout Mouse Model and iTRAQ-Based Proteomic Analysis. Proteomics Clin Appl. 2018 05; 12(3):e1700087.
-
Increased cysteinyl leukotriene concentration and receptor expression in tonsillar tissues of Chinese children with sleep-disordered breathing. Int Immunopharmacol. 2012 Aug; 13(4):371-6.